OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at firstname.lastname@example.org
Closing the gaps in complex therapy data remains a hurdle, but “getting clever” with AI can offer a path forward.
How Gilead readied remdesivir for the COVID challenge.
How the UK is making progress in this hi-tech field.
Looking Back at 1997–1999.
Amgen is collaborating on two digital health initiatives aimed at improving heart failure care and rehabilitation.
With COVID-19 severely disrupting the care of cancer patients in the UK, Astellas’ Jackie Williams talks about how UK pharma can partner with the NHS to address patient backlogs and support continuity of care.